USSTOCK.TODAY
Weekend. Closed
Log in Sign up

60 Degrees Pharmaceuticals Inc(SXTP) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today

SXTP
SXTP
60 Degrees Pharmaceuticals Inc
At close Nov 13 at 4:00 PM ET (Korea 11/14 06:00)
$0.52
+0.00 -0.19%
Nov 13 at 5:28 PM ET (Korea 11/14 07:28)
$0.51
-0.01 ▼ -1.53%

Full metrics table

Index ⓘ -P/E ⓘ -EPS (ttm) ⓘ -6.19Insider Own ⓘ 24.84%Shs Outstand ⓘ 2.7MPerf Week ⓘ -12.94%
Market Cap ⓘ 0.00BForward P/E ⓘ -EPS next Y ⓘ -Insider Trans ⓘ 0.85%Shs Float ⓘ 2.6MPerf Month ⓘ -42.39%
Enterprise Value ⓘ 0.01BPEG ⓘ -EPS next Q ⓘ -0.61Inst Own ⓘ 13.52%Short Float ⓘ 9.66%Perf Quarter ⓘ -52.05%
Income ⓘ -0.01BP/S ⓘ 1.5EPS this Y ⓘ 73.06%Inst Trans ⓘ 5%Short Ratio ⓘ 0.63Perf Half Y ⓘ -62.74%
Sales ⓘ 0.00BP/B ⓘ -EPS next 5Y ⓘ -ROA ⓘ -191.39%Short Interest ⓘ 0.26MPerf YTD ⓘ -74.53%
Book/sh ⓘ -2.61P/C ⓘ 1.78EPS past 3/5Y ⓘ 64.19% 37.74%ROE ⓘ -321.29%52W High ⓘ -93.99% ($8.62)Perf Year ⓘ -88.93%
Cash/sh ⓘ 0.29P/FCF ⓘ -Sales past 3/5Y ⓘ 40.21% -11.18%ROIC ⓘ -293.13%52W Low ⓘ 7.9% ($0.48)Perf 3Y ⓘ -99.64%
Dividend Est. ⓘ -EV/EBITDA ⓘ -EPS Y/Y TTM ⓘ 86.32%Gross Margin ⓘ 26.32%Volatility(W/M) ⓘ 13.19% 15.87%Perf 5Y ⓘ -
Dividend TTM ⓘ -EV/Sales ⓘ 8.62Sales Y/Y TTM ⓘ 24.77%Oper. Margin ⓘ -708.59%ATR (14) ⓘ 0.12Perf 10Y ⓘ -
Dividend Ex-Date ⓘ -Quick Ratio ⓘ 1.78EPS Q/Q ⓘ 81.96%Profit Margin ⓘ -709.19%RSI (14) ⓘ 30.27Recom ⓘ 2
Dividend Gr. 3/5Y ⓘ -Current Ratio ⓘ 2.32Sales Q/Q ⓘ -32.47%SMA20 ⓘ -34.17% ($0.79)Beta ⓘ 2.54Target Price ⓘ $3.7
Payout ⓘ -Debt/Eq ⓘ 0.06Earnings ⓘ 2026/8/14SMA50 ⓘ -44.97% ($0.94)Rel Volume ⓘ 0.06Prev Close ⓘ $0.52
Employees ⓘ 5LT Debt/Eq ⓘ 0.06EPS/Sales Surpr. ⓘ -22.45% 12.38%SMA200 ⓘ -68.04% ($1.63)Avg Volume(3M) ⓘ 0.41MPrice ⓘ $0.52
IPO ⓘ 2023/7/12Option/Short ⓘ No/YesTrades ⓘ 92Volume ⓘ 24,910Change ⓘ -0.19%
Company
SXTP SXTP60 Degrees Pharmaceuticals Inc | NASD | Biotechnology Deep dive

💊 60 Degrees Pharmaceuticals () is a specialty pharmaceutical company headquartered in Washington, D.C., focused on the prevention and treatment of infectious diseases. Its flagship product is Arakoda (tafenoquine), a malaria prevention drug. Although its revenue is very small, it is a micro-cap stock pursuing a strategy of boosting margins through a cash-pay model.

Quote

Over the past 1 year, on the lower side

94% below its 1-year high.

Now $0.52
52w low$0.4852w high$8.62
52W Range0%
Volume ⓘ 24,910

Traded less than usual. That is 6% of its average volume.

C
Overall · average, with some caution
We judged 6 of the 8 questions below. 2 rate excellent and 3 need caution.
No data for outlook, dividends, or not applicable.
Peer comparison Biotechnology

It ranks #578 of 598 in the industry

Based on market cap of $2M.

FAQ

FAQ

What kind of company is SXTP?

SXTP belongs to the Healthcare sector and operates in the Biotechnology industry.

What is the market cap of SXTP?

The market cap of SXTP is approximately $2M, ranking 5,800 within its sector.

What is the 52-week high and low for SXTP?

SXTP has recorded a 52-week high of $8.62 and a low of $0.48.

Telegram KakaoTalk
Briefs · earnings · signals, first Telegram · KakaoTalk channels